Health Catalyst, Inc. (HCAT) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
HCAT currently has 72.6M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 24.59% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 11, 2026 |
10-Q filing | 72.6M shares outstanding |
73M | 0 |
| Mar 12, 2026 |
10-K filing | 69.9M shares outstanding |
70M | 0 |
| Nov 10, 2025 |
10-Q filing | 70.4M shares outstanding |
70M | 0 |
| Aug 08, 2025 |
10-Q filing | 69.6M shares outstanding |
70M | 0 |
| May 09, 2025 |
10-Q filing | 68.6M shares outstanding |
69M | 0 |
| Feb 26, 2025 |
10-K filing | 70.2M shares outstanding |
70M | 0 |
| Nov 07, 2024 |
10-Q filing | 60.4M shares outstanding |
60M | 0 |
| Nov 06, 2024 |
8-K filing: Health Catalyst has agreed to issue approximately 2,200,490 shares of its common stock to the equity holders of Intraprise Health, LLC as part of the consideration for the acquisition of Intraprise Health, LLC, valued at $8.18 per share, with the acquisition expected to close by the end of 2024. |
59M | 0 |
| Aug 08, 2024 |
10-Q filing | 59.3M shares outstanding |
59M | 0 |
| May 10, 2024 |
10-Q filing | 58.6M shares outstanding |
59M | 0 |
| Feb 22, 2024 |
10-K filing | 56.4M shares outstanding |
56M | 0 |
| Nov 06, 2023 |
10-Q filing | 56.7M shares outstanding |
57M | 0 |
| Aug 09, 2023 |
10-Q filing | 56.0M shares outstanding |
56M | 0 |
| May 10, 2023 |
10-Q filing | 55.5M shares outstanding |
55M | 0 |
| Feb 28, 2023 |
10-K filing | 54.1M shares outstanding |
54M | 0 |
| Nov 09, 2022 |
10-Q filing | 54.3M shares outstanding |
54M | 0 |
| Aug 05, 2022 |
10-Q filing | 53.7M shares outstanding |
54M | 0 |
| May 10, 2022 |
10-Q filing | 53.2M shares outstanding |
53M | 0 |
| Mar 01, 2022 |
10-K filing | 53.3M shares outstanding |
53M | 0 |
| Nov 09, 2021 |
10-Q filing | 49.0M shares outstanding |
49M | 0 |
| Aug 13, 2021 |
8-K filing: Health Catalyst, Inc. completed an underwritten public offering of 4,245,283 shares of its common stock for net proceeds of approximately $213.1 million. ($213.1M proceeds) |
45M | 0 |
| Aug 06, 2021 |
10-Q filing | 44.9M shares outstanding |
45M | 0 |
| Jun 24, 2021 |
8-K filing: Health Catalyst, Inc. agreed to issue 830,704 shares of common stock to the equityholders of Twistle, Inc. as part of the consideration for the acquisition of Twistle, Inc., valued at $56.60 per share, with the potential for additional shares to be issued based on earn-out performance targets. |
44M | 0 |
| May 07, 2021 |
10-Q filing | 43.9M shares outstanding |
44M | 0 |
| Feb 25, 2021 |
10-K filing | 44.0M shares outstanding |
44M | 0 |
| Nov 10, 2020 |
10-Q filing | 42.5M shares outstanding |
42M | 0 |
| Aug 12, 2020 |
10-Q filing | 39.7M shares outstanding |
40M | 0 |
| May 13, 2020 |
10-Q filing | 38.0M shares outstanding |
38M | 0 |
| Feb 28, 2020 |
10-K filing | 37.3M shares outstanding |
37M | 0 |